Skip to content

A study to evaluate the effects of food ingredients on brain function

A study to evaluate the effects of food ingredients on brain function - A study to evaluate the effects of food ingredients on brain function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000052574
Enrollment
40
Registered
2023-10-23
Start date
2023-10-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Intake placebo beverage on the day Washout Intake test beverage on the day Intake test beverage on the day Washout Intake placebo beverage on the day

Sponsors

HUMA R&D CORP
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1.Healthy Japanese males who are between 20 and 35 years of age at the time of written informed consent. 2.BMI less than 25.0 kg/m2. 3.No smoker (No smoking past one year). 4.Subjects who are fully explained the purpose and details of the study, have ability to consent, are volunteering to participate in the study with a full understanding of the explanation, and have consented to participate in the study in writing.

Exclusion criteria

Exclusion criteria: 1.Receiving continuous pharmaceutical treatment with drugs including commercial pharmaceuticals and Chinese medicines due to some kind of illness excluding use as needed. 2.Receiving any dietary or exercise treatment under medical doctors. 3.Current or a history of mental disease, sleep disorder, hypertension, diabetes, dyslipidemia, or serious illness. 4.Current or a history of serious disorders of the liver, kidneys, heart, lungs, blood. 5.A gastrointestinal comorbidity or serious medical history. 6.Using implanted medical devices containing pacemakers or blood vessel clips. 7.A habit of taking drugs for treating diseases in past one month, excluding dismissal history of drugs for headaches, colds. 8.Have been taking any products (e.g., foods for specified health use, foods with functional health claims , health foods, drugs, quasi-drugs) that affect autonomic nervous system, metabolism and sleep, excluding who can quit intake during the study. 9.A constitutional difficulty in drinking alcohol. 10.At risk of developing hay fever or seasonal allergy symptoms or have allergic rhinitis during the study period. 11.Have or at risk of developing drug or food allergy symptoms. 12.Have difficulty wearing a heart rate monitor, such as an allergy to tape (such as bandage). 13.Alcohol drinkers, over 60 g/day of alcohol on daily basis. 14.Extremely irregular eating habits. 15.Night workers or Shift workers. 16.Under significant stress of any life event within 3 months before IC, or will have such a life event during the study period. 17.Have participated another clinical study within 1 month before IC, or will participate in it during the study period or within 1 month after the end of the study. 18.Cannot quit drinking from the day before the test date. 19.Have claustrophobia. 20.Current or a history of mental disorder containing depression.

Design outcomes

Primary

MeasureTime frame
fMRI

Secondary

MeasureTime frame
(Secondary outcomes) Questionnaire concerning psychological evaluation pulse rate (Safety evaluation) adverse events

Countries

Japan

Contacts

Public ContactHidemasa Toya

HUMA R&D CORP Clinical Development Department

toya@huma-rd.co.jp03-3431-1260

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026